NUVL (NUVL:NASDAQ) rocketted at $21.91, representing a gain of 20.1%. The stock appeared on our News Catalysts scanner on Fri, Jul 30, 2021 at 08:00 AM in the 'PUBLIC OFFERING' category.
The share price of the company has been moving sideways in recent weeks.
About NUVL (NUVL:NASDAQ)
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven...
Top 10 Gainers:
- Ever-Glory International Group, Inc. (EVK:NASDAQ), 124.78%
- Dolphin Entertainment, Inc. (DLPN:NASDAQ), 55.87%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 38.21%
- Atlas Technical Consultants, Inc. (ATCX:NASDAQ), 27.92%
- DIBS (DIBS:NASDAQ), 27.38%
- YOU (YOU:NYSE), 25.63%
- YMM (YMM:NYSE), 23.55%
- NUVL (NUVL:NASDAQ), 20.05%
- TNYA (TNYA:NASDAQ), 19.35%
- TRKA (TRKA:NASDAQ), 18.75%